TH2201005205A - A mixture of metal oxides (or hydroxides) combined with poorly soluble drugs, methods for producing the same, and pharmaceutical components containing the same. - Google Patents

A mixture of metal oxides (or hydroxides) combined with poorly soluble drugs, methods for producing the same, and pharmaceutical components containing the same.

Info

Publication number
TH2201005205A
TH2201005205A TH2201005205A TH2201005205A TH2201005205A TH 2201005205 A TH2201005205 A TH 2201005205A TH 2201005205 A TH2201005205 A TH 2201005205A TH 2201005205 A TH2201005205 A TH 2201005205A TH 2201005205 A TH2201005205 A TH 2201005205A
Authority
TH
Thailand
Prior art keywords
same
poorly soluble
hydroxides
mixture
producing
Prior art date
Application number
TH2201005205A
Other languages
Thai (th)
Inventor
คิม
Original Assignee
วีไบโอทรี โค
Filing date
Publication date
Application filed by วีไบโอทรี โค filed Critical วีไบโอทรี โค
Publication of TH2201005205A publication Critical patent/TH2201005205A/en

Links

Abstract

DEPCT66 03/11/2565 การประดิษฐ์นี้เกี่ยวข้องกับสิ่งผสมออกไซด์ (หรือไฮดรอกไซด์) ของโลหะซึ่งประกอบรวมด้วย ยาที่ละลายได้ไม่ดี, วิธีการสำหรับผลิตสิ่งเดียวกัน และองค์ประกอบเภสัชภัณฑ์ซึ่งประกอบรวมด้วยสิ่ง เดียวกัน ----------------------------------------------------------- DEPCT66 การประดิษฐ์นี้เกี่ยวข้องกับโลหะ (ไฮดรอก) คอมโพสิตที่ประกอบรวมด้วยยาที่ละลายได้ไม่ดี วิธีสำหรับการผลิตลิ่งเดียวกัน และองค์ประกอบทางเภสัชกรรมที่ประกอบรวมด้วยสิ่งเดียวกัน -----------------------------------------------------------DEPCT66 03/11/2022 This invention relates to metal (hydroxide) composites containing a poorly soluble drug, a method for manufacturing the same drug, and pharmaceutical components containing the same drug. ----------------------------------------------------------- DEPCT66 This invention relates to metal (hydroxide) composites containing a poorly soluble drug, a method for manufacturing the same drug, and pharmaceutical components containing the same drug. -----------------------------------------------------------

TH2201005205A 2021-09-28 A mixture of metal oxides (or hydroxides) combined with poorly soluble drugs, methods for producing the same, and pharmaceutical components containing the same. TH2201005205A (en)

Publications (1)

Publication Number Publication Date
TH2201005205A true TH2201005205A (en) 2026-03-16

Family

ID=

Similar Documents

Publication Publication Date Title
MY161079A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
JOP20220002B1 (en) Processes and intermediate compound for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridine-2-yl]-benzamide hemisuccinate, and the preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridine-2-yl]-benzamide acetate
ECSP024341A (en) PHARMACEUTICAL COMPOSITIONS
MX2016011219A (en) Process for manufacturing glatiramer acetate product.
PH12019501955A1 (en) Tri-cycle compound and applications thereof
CY1114157T1 (en) TYPES OF SILVER, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL CONTAINERS
HK1203815A1 (en) Pharmaceutical compositions and methods for their preparation
ZA201902049B (en) Pharmaceutical composition
WO2019194773A3 (en) The combination comprising linagliptin and metformin
PL4091603T3 (en) METAL (HYDR)OXIDE COMPOSITE COMPRISING A SLIGHTLY SOLUBLE DRUG, A METHOD OF MANUFACTURING THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
PH12021550766A1 (en) New compound, preparation method and use thereof
MX2022006489A (en) Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof.
FI20155779A7 (en) Sustained-release non-steroidal anti-inflammatory drug delivery
EP3266767A3 (en) Method for preparing an antifibrotic agent
WO2017068388A3 (en) Use of synthetic pntx-19 peptide for the treatment of pain
PL426731A1 (en)
WO2015130963A3 (en) Compositions and methods for administering insulin or insulin-like protein to the brain
WO2019004776A3 (en) Composite chewable tablet including levocetirizine and montelukast with improved stability and drug compliance, and method of preparing the same
MX2021015930A (en) Pharmaceutical compositions for glucagon and glp-1 co-agonist peptides.
HUE064344T2 (en) Pharmaceutical compound, the method of its making and use as medicinal agent
MX2021006947A (en) Enhanced herbal smoking blend.
ZA202210370B (en) Method for improving the stability of a pharmaceutical composition comprising a high penetration drug, and the pharmaceutical composition obtained therefrom
TH146097A (en) Citidine analog formulation for oral administration And how to use the formula
TN2015000209A1 (en) Production of "salami" stabilized and colored by the powder of fig of barbarism
TH1701006062A (en) New pyridinium composition